Ascletis Announces Oral Discussion of ASC36_35 FDC Preclinical Data Demonstrating Superior Weight Loss to Eloralintide/Tirzepatide Combination at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting
- Fixed-dose combination of ASC36 and ASC35 (ASC36_35 FDC) demonstrated superior weight loss compared to eloralintide in combination with tirzepatide in a diet-induced obese (DIO) animal model. HONG KONG, July 23, 2026 /PRNewswire/ -- Ascletis...
Ariel Green Pays Technology Performance Insurance Claim for Plastic Recycling Facility, Demonstrating Protection for Clean Energy Projects
Claim Proves How Technology Performance Insurance Protects Clean Energy Investments and Supports Continued Operations LONDON, July 15, 2026 /PRNewswire/ -- Ariel Green today announced the payment of a Technology Performance Insurance (TPI) claim for...
2026 IB Results: A Testament to Holistic Education As 208 YCYW Students Secure Outstanding Global Results
HONG KONG, July 8, 2026 /PRNewswire/ -- The results for the International Baccalaureate Diploma Programme (IBDP) were recently released, and the Class of 2026 of YCYW Education Network (YCYW) has once again achieved outstanding results. This year, A...
Nota AI Has Two MoE Quantization Papers Accepted at ICML 2026 Workshop, Demonstrating Global Competitiveness in Large-Scale AI Optimization
Two papers on MoE-specific quantization algorithms accepted at a workshop held in conjunction with ICML 2026 Recognition follows Nota AI's overall win at the NVIDIA Nemotron Hackathon Strengthening core optimization technologies to make large-scale...
Caliway Unveils Latest OI25 Animal Study Data for CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies at ADA 2026, Demonstrating Dual Potential to Attenuate Post-Discontinuation Weight Regain and Improve Metabolic Health
Backed by International Authority — Caliway's latest preclinical data on its proprietary localized fat reduction candidate, CBL-514, in combination with GLP–1R–based weight–loss therapies, were presented at the American Diabetes Association 2026...
Foretellix Unveils Reference Solution Integrating NVIDIA Alpamayo to Scale AI Autonomous Vehicle Development
SUNNYVALE, Calif., June 1, 2026 /PRNewswire/ -- Foretellix, provider of safety and data infrastructure for physical AI, today announced its Reference Solution for the NVIDIA Alpamayo ecosystem. Foretellix enables developers building AI-powered...
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Selected for Oral Presentation at WCLC 2026, Demonstrating Sustained Breakthrough Efficacy Signals in NSCLC
NANJING, China, May 28, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that the Phase II clinical study of its proprietary PD-L1/4-1BB bispecific antibody, Opamtistomig...
AION UT Global Launch Drives Strong Sales Across Key Markets and Multiple International Honors
GUANGZHOU, China, May 27, 2026 /PRNewswire/ -- Since its 2025 global debut, the AION UT has rapidly gained traction across Southeast Asia, South America, and Europe. In Q1, it delivered over 2,400 units in Thailand—securing a Top 3 position in the...
Neurovia AI, a Subsidiary of Robo.ai, Concludes Participation at ISNR2026, Demonstrating NeuroStream™ Visual Data Infrastructure and 96.37% Visually Lossless Compression
ABU DHABI, UAE, May 21, 2026 /PRNewswire/ -- Neurovia AI, an artificial intelligence data processing and compression technology provider and a subsidiary of Robo.ai Inc. (NASDAQ: AIIO), announced the conclusion of its inaugural presentation at the...
UN Global Compact Africa Business Leaders Coalition Unveils New Roadmap to Accelerate Intra-African Trade and Sustainable Growth
KIGALI, Rwanda, May 16, 2026 /PRNewswire/ -- The Africa Business Leaders Coalition (ABLC), a CEO-led platform convened by the UN Global Compact to bring together leading African CEOs and companies to advance sustainable growth, climate action,...